Clinical Trial Update: Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating nimotuzumab with cisplatin/radiotherapy in locally advanced head and neck squamous cell cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED